期刊文献+

人表皮生长因子受体、表皮生长因子受体-2和环氧合酶-2在胃癌中的表达及意义 被引量:2

Expressions and Significance of Epidermal Growth Factor Receptor,HER-2 and Cyclooxygenase-2 in Gastric Carcinoma
原文传递
导出
摘要 目的探讨胃癌组织中人表皮生长因子受体(EGFR)、表皮生长因子受体-2(HER-2)和环氧合酶-2(COX-2)的表达及与临床病理特征的关系。方法应用免疫组织化学Envision二步法,检测70例胃癌组织中EGFR、HER-2和COX-2的表达情况,并结合其临床病理特点进行分析。结果 EGFR、HER-2和COX-2在胃癌组织中的表达阳性率分别为35.7%(25/70)、27.1%(19/70)、67.1%(47/70)。阳性表达与肿瘤分化程度、侵袭深度、有无淋巴结转移及TNM分期有关(P<0.05),而与患者的性别及年龄、肿瘤部位和大小无关(P>0.05)。EGFR、HER-2和COX-2三者之间在胃癌组织中的表达均呈正相关(P<0.05)。结论 EGFR、HER-2和COX-2的表达参与胃癌的生长、侵袭和转移过程。它们的联合检测有助于胃癌患者靶向药物的选择,也为胃癌的预后判断提供客观的参考指标。 Objective To observe the expressions of epidermal growth factor receptor(EGFR),HER-2 and cyclooxygenase-2(COX-2) in gastric carcinoma(GC) and to explore the relationship among them.Methods The envision immunohistochemical stain method was used to detect EGFR,HER-2 and COX-2 protein expressions in sample of 70 GC tissues.And their corresponding pathologic features were analyzed.Results The positive expression rates of EGFR,HER-2 and COX-2 protein in GC tissue were 35.7%(25/70),27.1%(19/70) and 67.1%(47/70), respectively.The positive expression rates were closely relevant to the differentiation of the cancer,invasion depth, lymphatic metastasis and TNM(P0.05),but not to the patient' s sex,age,tumor site and size(P0.05).There was a stable positive correlation among EGFR,HER-2 and COX-2 expressions in GC tissues,respectively.Conclusions EGFR,HER-2 and COX-2 expressions participate in the development,invasion and metastasis process of GC.Combined detection can be regarded as an important symbol for guiding the molecular targeting therapy of GC,and judging the prognosis of GC.
出处 《华西医学》 CAS 2012年第1期66-69,共4页 West China Medical Journal
关键词 胃癌 表皮生长因子受体 环氧合酶-2 免疫组织化学 Gastric carcinoma Epidermal growth factor receptor Cyclooxygenase-2 Immunohistochemistry
  • 相关文献

参考文献2

二级参考文献31

  • 1Vane J, Botting R. Mechanism of action of anti-inflammatory drugs. Int J Tissue React 1998; 20:3-15.
  • 2Sung JJ, Leung WK, Go MY, To KF, Cheng AS, Ng EK, ChanFK. Cyclooxygenase-2 expression in Helicobacter pylori-associated premalignant and malignant gastric lesions. Am J Pathol 2000; 157:729-735.
  • 3Leung WK, To KF, Ng YP, Lee TL, Lau JY, Chan FK, Ng EK,Chung SC, Sung JJ. Association between cyclo-oxygenase-2 overexpression and missense p53 mutations in gastric cancer.Br J Cancer 2001; 84:335-339.
  • 4Pairet M, Engelhardt G. Distinct isoforms (COX-1 and COX-2) of cyclooxygenase: possible physiological and therapeutic implications. Fundam Clin Pharmacol 1996; 10:1-15.
  • 5Williams CS, Mann M, DuBois RN. The role of cyclooxygenases in inflammation, cancer, and development. Oncogene 1999; 18:7908-7916.
  • 6Sawaoka H, Kawano S, Tsuji S, Tsujii M, Gunawan ES, Takei Y, Nagano K, Hori M. Cyclooxygenase-2 inhibitors suppress the growth of gastric cancer xenografts via induction of apoptosis in nude mice. Am J Physiol 1998; 274(6 Pt 1): G1061-1067.
  • 7Charalambous D, O'Brien PE. Inhibition of colon cancer precursors in the rat by sulindac sulphone is not dependent on inhibition of prostaglandin synthesis. J Gastroenterol Hepatol 1996; 11:307-310.
  • 8Elder DJ, Halton DE, Hague A, Paraskeva C. Induction of apoptotic cell death in human colorectal carcinoma cell lines bya cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression.Clin Cancer Res 1997; 3:1679-1683.
  • 9Hanif R, Pittas A, Feng Y, Koutsos MI, Qiao L, Staiano-Coico L, Shiff SI, Rigas B. Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway. Biochem Pharmacol 1996; 52:237-245.
  • 10Chan TA. Non-steroidal anti-inflammatory drugs, apoptosis,and colon-cancer chemoprevention. Lancet Oncol 2002; 3:166-174.

共引文献41

同被引文献14

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部